AeroLeads people directory · profile

David Johnson Email & Phone Number

Founder and CEO at GigaMune at GigaMune
Location: San Francisco, California, United States 6 work roles 6 schools
1 work email found @gigagen.com 4 phones found area 415 and 650 LinkedIn matched
✓ Verified May 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 4 phones

Work email d****@gigagen.com
Direct phone (415) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Founder and CEO at GigaMune
Location
San Francisco, California, United States

Who is David Johnson? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

David Johnson is listed as Founder and CEO at GigaMune at GigaMune, based in San Francisco, California, United States. AeroLeads shows a work email signal at gigagen.com, phone signal with area code 415, 650, and a matched LinkedIn profile for David Johnson.

David Johnson previously worked as Founder and CEO at Gigamune and Angel Investor at El Poblenou Llc. David Johnson holds Ph.D., Genetics from Stanford University.

Company email context

Email format at GigaMune

This section adds company-level context without repeating David Johnson's masked contact details.

{first_initial}{last}@gigagen.com
86% confidence

AeroLeads found 1 current-domain work email signal for David Johnson. Compare company email patterns before reaching out.

Profile bio

About David Johnson

Dr. David Johnson is an inventor, entrepreneur, and expert in genomics with a track record of bringing new medical technologies to the clinic and the market. Dr. Johnson is Founder and CEO of GigaMune, which is developing novel technology for in vivo targeted gene delivery of T cell receptors (TCRs) and chimeric antigen receptors (CARs) to treat serious diseases such as cancer and autoimmune diseases. Our vision is to bring gene therapy into mainstream medicine through in vivo delivery of any gene to any cell in any tissue location. Our initial goal is to challenge conventional ex vivo cell therapy manufacturing by reducing costs and improving outcomes. Previously, Dr. Johnson brought GigaGen's massively diverse recombinant polyclonal antibody drugs from concept to clinic, including three INDs and over $100 million in government contracts. Dr. Johnson led negotiation and sale of the company to Grifols for a company valuation of $142.9 million (with potential for further product-related earnout) in March 2021. Also, Dr. Johnson was among the founding members and COO of Natera (NASDAQ: NTRA), a molecular diagnostics firm recently valued at $9 billion. Prior to Natera he was the ENCODE Project Director at the Stanford Human Genome Center. Dr. Johnson holds a BS in Biology from Duke University, a PhD in Genetics from Stanford University, and an MBA from the Haas School of Business at the University of California, Berkeley.

Listed skills include Biotechnology, Genomics, Molecular Biology, Start Ups, and 10 others.

Current workplace

David Johnson's current company

Company context helps verify the profile and gives searchers a useful next step.

GigaMune
Gigamune
Founder and CEO at GigaMune
AeroLeads page
6 roles

David Johnson work experience

A career timeline built from the work history available for this profile.

Founder And Ceo

Current

GigaMune is developing novel technology for in vivo targeted gene delivery of T cell receptors (TCRs) and chimeric antigen receptors (CARs) to treat serious diseases such as cancer and autoimmune diseases. Our vision is to bring gene therapy into mainstream medicine through in vivo delivery of any gene to any cell in any tissue location. Our initial goal.

Jan 2022 - Present

Angel Investor

Current

San Francisco, CA, US

El Poblenou LLC is my private office investing in early stage biotechnology companies. I am particularly interested to back first-time technical entrepreneurs where I can provide value as an adviser. My investments include FormaPath (https://www.formapath.com/), Tensor Bio (https://www.tensorbio.com/), and Lynx Bio (https://www.lynx.bio/).

Feb 2022 - Present

Entrepreneur In Residence

Illumina Ventures is an independently managed firm focused on early-stage companies that are pioneering new applications of genomics and enabling precision medicine. We invest in life science tools, clinical diagnostics, therapeutics, and other opportunities to improve human health. Our strategic relationship with Illumina provides us access to the.

Feb 2022 - Feb 2023

Founder And Ceo

San Carlos, California, US

Headquartered in South San Francisco, CA, GigaGen is advancing transformative antibody drugs for immune deficiency, infectious diseases and checkpoint resistant cancers by leveraging industry-leading, single-cell technologies. GigaGen’s novel technology platforms uniquely capture and recreate complete immune repertoires as functional antibody libraries..

May 2010 - Oct 2021

Chief Operating Officer, Svp Of Research And Development

Austin, Texas, US

  • Directed development and delivery of reproductive genetics laboratory service products that rapidly dominated the market, and improved clinical outcomes.Natera (NASDAQ: NTRA) provides molecular diagnostic services for.
  • Built a molecular diagnostics lab from concept to clinical testing within one year.
  • Scaled lab to win 30% market share one year after launch.
  • Secured >$1.6 million in nondilutive financing through NIH/NICHD.
  • Negotiated commercial partnerships with Ferring Pharmaceutical and Illumina.
  • Published clinical findings in Molecular Human Reproduction and Human Reproduction.
Jan 2006 - May 2010

Encode Project Director

Palo Alto, California, US

  • Directed production genomics research group with $1 million annual budget and internationally recognized stature.The Stanford Human Genome Center used the latest molecular genomic technologies to sequence and.
  • Invented a novel genomic measurement technology (ChIP-seq), now used by 200+ labs globally.
  • Wrote a successful $14.6 million research grant from NIH for large-scale ChIP-seq experiments.
  • Successfully negotiated research collaborations with Solexa (acquired by Illumina).
  • Published findings in Science, Genome Research, and Nature Methods.
Jan 2006 - Nov 2007
6 education records

David Johnson education

Ph.D., Genetics

Stanford University

Master Of Business Administration (Mba)

University Of California, Berkeley, Haas School Of Business

Ab, Biology

Duke University

Graduate Certificate, Applied Statistics

Penn State University

Visiting Student, Genetics

Tokyo Institute Of Technology

Visiting Student, Biology

Universidad San Francisco De Quito
FAQ

Frequently asked questions about David Johnson

Quick answers generated from the profile data available on this page.

What company does David Johnson work for?

David Johnson works for GigaMune.

What is David Johnson's role at GigaMune?

David Johnson is listed as Founder and CEO at GigaMune at GigaMune.

What is David Johnson's email address?

AeroLeads has found 1 work email signal at @gigagen.com for David Johnson at GigaMune.

What is David Johnson's phone number?

AeroLeads has found 4 phone signal(s) with area code 415, 650 for David Johnson at GigaMune.

Where is David Johnson based?

David Johnson is based in San Francisco, California, United States while working with GigaMune.

What companies has David Johnson worked for?

David Johnson has worked for Gigamune, El Poblenou Llc, Illumina Ventures, Gigagen, Inc, and Natera.

How can I contact David Johnson?

You can use AeroLeads to view verified contact signals for David Johnson at GigaMune, including work email, phone, and LinkedIn data when available.

What schools did David Johnson attend?

David Johnson holds Ph.D., Genetics from Stanford University.

What skills is David Johnson known for?

David Johnson is listed with skills including Biotechnology, Genomics, Molecular Biology, Start Ups, Bioinformatics, Entrepreneurship, Commercialization, and Immunology.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.